Convention Background

Global Precision Medicine Plan is in tremendous progress. Among this, the next-generation sequencing, as the representative for nowadays biotechnology, has become the most significant science and technology project for China’s 13th Plan from 2016-2020. However, the emphasis of Precision Medicine is Precision. It is not only simply gene sequencing, but also accurate diagnosis and precise treatment. Under the cross utilization and development of bioinformatics and big data, the novel medical concept, drug R&D, and treatment mode has received more and more attention.

In connection of genomics, medical big data, liquid biopsy, oncology drug R&D and companion diagnostics, biomarker is P4 China 2017’s main theme this year after P4 2016’s successful launch. P4 2017 has 1 main conference, 3 parallel forums and 1 project partnering seminar, to bring the PM industry diversified thinking and in-depth analysis from technological pain points, difficulties and challenges.